A new look at the treatment of severe hypertension.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002740:Chlorothiazide / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003981:Diazoxide / Q000627:therapeutic use; D004357:Drug Synergism; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008464:Mecamylamine / Q000627:therapeutic use; D008750:Methyldopa / Q000627:therapeutic use; D008875:Middle Aged; D010919:Placebos; D013148:Spironolactone / Q000008:administration & dosage / Q000627:therapeutic use; D013843:Thiazines / Q000627:therapeutic use; D014511:Uremia / Q000150:complications
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D010919:Placebos; D013843:Thiazines; D013148:Spironolactone; D008750:Methyldopa; D008464:Mecamylamine; D002740:Chlorothiazide; D003981:Diazoxide